BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 11.01B
Enterprise value 10.54B
Trailing P/E N/A
Forward P/E 25.97
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)3.97
Price/book (mrq)1.13
Enterprise value/revenue 3.79
Enterprise value/EBITDA -160.88

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-30.40%
S&P500 52-week change 33.90%
52-week high 3572.70
52-week low 3344.63
50-day moving average 3429.69
200-day moving average 3438.75

Share statistics

Avg vol (3-month) 3192.79k
Avg vol (10-day) 3251.3k
Shares outstanding 524.54M
Implied shares outstanding 6N/A
Float 821.09M
% held by insiders 114.53%
% held by institutions 179.70%
Shares short (14 May 2023) 4291.14k
Short ratio (14 May 2023) 41.35
Short % of float (14 May 2023) 41.37%
Short % of shares outstanding (14 May 2023) 40.98%
Shares short (prior month 13 Apr 2023) 4274.42k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -6.88%
Operating margin (ttm)14.97%

Management effectiveness

Return on assets (ttm)1.86%
Return on equity (ttm)-1.92%

Income statement

Revenue (ttm)2.78B
Revenue per share (ttm)93.57
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)1.57B
EBITDA 555.52M
Net income avi to common (ttm)-191.23M
Diluted EPS (ttm)-6.94
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.85B
Total cash per share (mrq)62.53
Total debt (mrq)1.38B
Total debt/equity (mrq)14.15
Current ratio (mrq)5.56
Book value per share (mrq)329.76

Cash flow statement

Operating cash flow (ttm)242.02M
Levered free cash flow (ttm)103.6M